These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 15313405

  • 1. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS, Surh YJ.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS, Kim SH, Song YS, Surh YJ.
    Carcinogenesis; 2004 May 15; 25(5):713-22. PubMed ID: 14729583
    [Abstract] [Full Text] [Related]

  • 3. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S, Inoue H, Flowers LC, Sidell N.
    Clin Cancer Res; 2003 Oct 01; 9(12):4627-35. PubMed ID: 14555539
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.
    Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Tellez C, Williams S, Jung YD, Fan F, Takeda A, Akagi M, Bar-Eli M, Gallick GE, Ellis LM.
    Cancer Res; 2003 Jul 01; 63(13):3632-6. PubMed ID: 12839952
    [Abstract] [Full Text] [Related]

  • 6. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 7. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved.
    Hou DX, Yanagita T, Uto T, Masuzaki S, Fujii M.
    Biochem Pharmacol; 2005 Aug 01; 70(3):417-25. PubMed ID: 15963474
    [Abstract] [Full Text] [Related]

  • 8. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X, Yue P, Zhou Z, Khuri FR, Sun SY.
    J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759
    [Abstract] [Full Text] [Related]

  • 9. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM.
    J Environ Pathol Toxicol Oncol; 2002 Dec 01; 21(2):183-91. PubMed ID: 12086405
    [Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A.
    Novartis Found Symp; 2004 Dec 01; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [Abstract] [Full Text] [Related]

  • 11. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A, Fernandez PM, Chughtai OR, Kaiser HE.
    In Vivo; 2002 Dec 01; 16(6):501-9. PubMed ID: 12494894
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
    Wu R, Abramson AL, Shikowitz MJ, Dannenberg AJ, Steinberg BM.
    Clin Cancer Res; 2005 Sep 01; 11(17):6155-61. PubMed ID: 16144915
    [Abstract] [Full Text] [Related]

  • 13. Approach to angiogenesis inhibition based on cyclooxygenase-2.
    Masferrer J.
    Cancer J; 2001 Sep 01; 7 Suppl 3():S144-50. PubMed ID: 11779086
    [Abstract] [Full Text] [Related]

  • 14. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
    Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, Pinzani M, Laffi G, Abboud HE, Gentilini P, Marra F.
    Hepatology; 2001 Mar 01; 33(3):713-21. PubMed ID: 11230753
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K, Akay MT, Abbasoglu O, Ercan A.
    Cancer Detect Prev; 2004 Mar 01; 28(2):127-42. PubMed ID: 15068837
    [Abstract] [Full Text] [Related]

  • 16. Molecular pathology of cyclooxygenase-2 in neoplasia.
    Fosslien E.
    Ann Clin Lab Sci; 2000 Jan 01; 30(1):3-21. PubMed ID: 10678579
    [Abstract] [Full Text] [Related]

  • 17. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B, Deutsch E, Eschwege P, De Crevoisier R, Nasr E, Eschwege F, Bourhis J.
    J Urol; 2003 Nov 01; 170(5):2036-9. PubMed ID: 14532848
    [Abstract] [Full Text] [Related]

  • 19. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK, Narayanan BA, Reddy BS.
    Int J Oncol; 2005 Mar 01; 26(3):785-92. PubMed ID: 15703837
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 01; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.